A few generic and brand names of GLP-1 agonists, according to the Johns Hopkins Patient Guide to Diabetes, include: Each brand has its own recommended dosage and frequency of intake. Some may be ...

Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.

The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S. litigation ...

This story mentions weight, weight loss, and/or GLP-1 drugs. In the last ... of GLP-1s from its shortage list should mean any ...

People are taking tiny amounts of GLP-1, short for glucagon-like peptide 1 and sold under brand names like Ozempic, Wegovy and Mounjaro to treat diabetes and obesity. Sarah Laing is a Toronto ...

As popular as they are, GLP-1 medications aren’t cheap. Brand-name prescriptions cost upward ... selling direct-to-consumers well below list price. Last summer, Eli Lilly began to offer a ...

The ADA issued a statement recommending against use of non-FDA-approved GLP ... brand-name versions of the drugs. “The ADA recommends against using non-FDA-approved compounded GLP-1 and dual ...

Share on Pinterest People who rely on compounded GLP-1 drugs say they might not be able to afford brand-name versions, which are often not covered by insurance. Iuliia Burmistrova/Getty Images The ...